Medtronic plc CEO Geoff Martha highlighted his company’s neuroscience portfolio during his presentation at the conference.
“In our neuromodulation business, where we ceded share over the last few years, we're now back on the offensive,” he said
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?